EUVIMEDEUVIMED entdecken
Crossref

Artificial Intelligence-Driven Discovery of Medicinal Plant Bio-actives Integrating Ethnobotanical Databases, Metabolomics, and Molecular Docking

Talari Parameshwari

Biotechnology Frontiers · 10.07.2024 · 4 (2) · 03-12

DOI: 10.51470/bf.2024.4.2.03 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Frontiers, online erschienen am 02.08.2024. Verfasst von Talari Parameshwari.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medicinal plants represent an important reservoir of structurally diverse bioactive compounds with potential applications in drug discovery, disease prevention, and therapeutic development. However, the identiication and characterization of pharmacologically relevant phytochemicals remain challenging because of the chemical complexity of plant extracts, variations in phytochemical composition, incomplete documentation of traditional medicinal knowledge, and limitations associated with conventional screening approaches. Recent advances in artiicial intelligence (AI), machine learning (ML), metabolomics, and molecular modelling have created opportunities to accelerate the systematic discovery of plant-derived bioactive compounds. This examines an integrated computational and experimental framework for medicinal plant bioactive discovery, emphasizing the convergence of ethnobotanical databases, metabolomics proiling, artiicial intelligence, and molecular docking. Ethnobotanical information provides a knowledge-based foundation for prioritizing medicinal species, plant parts, traditional applications, and therapeutic indications. Metabolomics technologies, particularly liquid chromatography–mass spectrometry (LC–MS), gas chromatography–mass spectrometry (GC–MS), and nuclear magnetic resonance (NMR) spectroscopy, facilitate the comprehensive identiication and characterization of plant metabolites. Artiicial intelligence approaches, including supervised learning, unsupervised clustering, natural language processing, deep learning, and network-based prediction, can integrate heterogeneous datasets and identify relationships between phytochemical structures, biological targets, and pharmacological activities. Molecular docking and molecular dynamics simulations further support the assessment of predicted ligand–target interactions and their structural stability. The integration of these technologies offers a promising strategy for prioritizing candidate bioactive compounds, identifying potential molecular targets, and developing testable hypotheses for experimental investigation and challenges associated with data standardization, ethnobotanical knowledge protection, metabolite annotation, model interpretability, computational reproducibility, and experimental validation remain important considerations. An integrated and ethically responsible AI-assisted discovery framework could strengthen evidence-based medicinal plant research and contribute to the development of natural-product-inspired therapeutic candidates.

Zitieren

APA

Parameshwari, T. (2024). Artificial Intelligence-Driven Discovery of Medicinal Plant Bio-actives Integrating Ethnobotanical Databases, Metabolomics, and Molecular Docking. Biotechnology Frontiers, 4(2), 03-12. https://doi.org/10.51470/bf.2024.4.2.03

Vancouver

Parameshwari T. Artificial Intelligence-Driven Discovery of Medicinal Plant Bio-actives Integrating Ethnobotanical Databases, Metabolomics, and Molecular Docking. Biotechnology Frontiers. 2024;4(2):03-12. doi:10.51470/bf.2024.4.2.03

BibTeX
@article{Parameshwari2024,
  author = {Parameshwari, Talari},
  title = {Artificial Intelligence-Driven Discovery of Medicinal Plant Bio-actives Integrating Ethnobotanical Databases, Metabolomics, and Molecular Docking},
  journal = {Biotechnology Frontiers},
  year = {2024},
  volume = {4},
  number = {2},
  pages = {03--12},
  doi = {10.51470/bf.2024.4.2.03}
}
Kostenlos starten →